StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$14.01−0.54 (-3.71%)

Close on Nov 19, 2026Market cap $1.01BP/E –Yield –

Omeros free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Omeros's free cash flow for the twelve months ending Jun 30, 2026 was -$68.73M. For fiscal 2025 it was -$116.16M. The highest annual figure on record is $74.30M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$116.16M–
FY2024Dec 31, 2024-$148.97M-300.5%
FY2023Dec 31, 2023$74.30M–
FY2022Dec 31, 2022-$86.60M–
FY2021Dec 31, 2021-$110.00M–
FY2020Dec 31, 2020-$100.37M–
FY2019Dec 31, 2019-$60.41M–
FY2018Dec 31, 2018-$104.30M–
FY2017Dec 31, 2017-$36.58M–
FY2016Dec 31, 2016-$51.63M–
FY2015Dec 31, 2015-$65.45M–
FY2014Dec 31, 2014-$58.07M–
FY2013Dec 31, 2013-$29.90M–
FY2012Dec 31, 2012-$35.19M–
FY2011Dec 31, 2011-$26.91M–
FY2010Dec 31, 2010-$15.31M–
FY2009Dec 31, 2009-$19.31M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.10M–
Q1 FY2026Mar 31, 2026-$14.51M–
Q4 FY2025Dec 31, 2025-$39.84M–
Q3 FY2025Sep 30, 2025-$18.48M–
Q2 FY2025Jun 30, 2025-$21.95M–
Q1 FY2025Mar 31, 2025-$35.88M–
Q4 FY2024Dec 31, 2024-$29.01M–
Q3 FY2024Sep 30, 2024-$32.06M–
Q2 FY2024Jun 30, 2024-$46.07M–
Q1 FY2024Mar 31, 2024-$41.84M-124.0%
Q4 FY2023Dec 31, 2023-$34.94M–
Q3 FY2023Sep 30, 2023-$32.68M–
Q2 FY2023Jun 30, 2023-$32.62M–
Q1 FY2023Mar 31, 2023$174.54M–
Q4 FY2022Dec 31, 2022-$25.40M–
Q3 FY2022Sep 30, 2022-$26.44M–
Q4 FY2021Dec 31, 2021-$18.29M–
Q1 FY2021Mar 31, 2021-$40.27M–
Q4 FY2020Dec 31, 2020-$18.41M–
Q3 FY2020Sep 30, 2020-$35.01M–
Q2 FY2020Jun 30, 2020-$37.74M–
Q1 FY2020Mar 31, 2020-$9.21M–
Q4 FY2019Dec 31, 2019-$23.03M–
Q3 FY2019Sep 30, 2019-$7.56M–
Q2 FY2019Jun 30, 2019-$16.69M–
Q1 FY2019Mar 31, 2019-$13.13M–
Q4 FY2018Dec 31, 2018-$24.75M–
Q3 FY2018Sep 30, 2018-$36.96M–
Q2 FY2018Jun 30, 2018-$31.11M–
Q1 FY2018Mar 31, 2018-$11.48M–
Q4 FY2017Dec 31, 2017-$4.17M–
Q3 FY2017Sep 30, 2017-$11.23M–
Q2 FY2017Jun 30, 2017-$8.40M–
Q1 FY2017Mar 31, 2017-$12.77M–
Q4 FY2016Dec 31, 2016-$10.91M–
Q3 FY2016Sep 30, 2016-$11.26M–
Q2 FY2016Jun 30, 2016-$12.83M–

More Omeros figures

See a number that looks wrong?